Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes have?
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes has 16 citations in the OpenAlex counts ScholarIQ stores.
When was Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes published?
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes has 2021 year in the ScholarIQ index.
What is the open-access status of Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes?
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes has bronze oa status in the ScholarIQ index.
What is the DOI of Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes?
The DOI for Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes is on the source record.
What is the PMID of Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes?
The PMID for Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes is on the source record.
What is the OpenAlex record for Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes?
The OpenAlex for Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromes is on the source record.